Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy

BACKGROUND: Prevention of bone metastases is a major issue for breast cancer patients, as it would improve quality of life in a population where long survival is anticipated. PATIENTS AND METHODS: Early breast cancer patients, who had been treated with anthracycline-based chemotherapy within two ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Timotheadou, Eleni, Kalogeras, Konstantine T., Koliou, Georgia-Angeliki, Wirtz, Ralph M., Zagouri, Flora, Koutras, Angelos, Veltrup, Elke, Christodoulou, Christos, Pentheroudakis, George, Tsiftsoglou, Aris, Papakostas, Pavlos, Aravantinos, Gerasimos, Venizelos, Vasilios, Pectasides, Dimitrios, Kosmidis, Paris, Karanikiotis, Charisios, Markopoulos, Christos, Gogas, Helen, Fountzilas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Short communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491451/
https://www.ncbi.nlm.nih.gov/pubmed/28666187
http://dx.doi.org/10.1016/j.tranon.2017.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491451/
https://www.ncbi.nlm.nih.gov/pubmed/28666187
http://dx.doi.org/10.1016/j.tranon.2017.05.006

Ejemplares similares